Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.

"Duality of Interest. H.H. owns stocks and is the chairman of the board of Vactech Ltd, which develops vaccines against picornaviruses. H.H. and M.F.-T. serve on the scientific advisory board of Provention Bio Inc., which is developing a clinical CVB vaccine in collaboration with Vactech Ltd. No other potential conflicts of interest relevant to this article were reported."

"Funding. Financial support was received from Barndiabetesfonden (Swedish Child Diabetes Foundation), Diabetesfonden (the Swedish Diabetes Foundation), Karolinska Institutet, including the Strategic Research Program in Diabetes, Business Finland (formerly TEKES, Therdiab project, diary no. 1843/31/2014), the Academy of Finland (grant 309455 awarded to M.M.H. and grant 288671 awarded to H.H.), the Sigrid Juséliuksen Säätiö (Sigrid Jusélius Foundation), the Reino Lahtikari Foundation and the JDRF (2-SRA-2017-A-N)."